Image of the paper-based isotachophoresis (ITP) device that isolates, enriches, and detects exosomes from a prostate cancer cell line.
Washington State University researchers have developed a technology that is more than 30 times more sensitive than current lab-based tests in finding early stage cancer biomarkers in blood.
The technology uses an electric field to concentrate and separate cancer biomarkers onto a paper strip. It could someday become a kind of liquid biopsy and could lead to earlier detection of and faster treatments for cancer, a disease that causes more than 9.6 million deaths a year around the world.
Led by Wenji Dong, associate professor in the Gene and Linda Voiland School of Chemical Engineering and Bioengineering, and graduate student Shuang Guo, the researchers were able to detect miniscule levels of the cancer markers in tiny extracellular bubbles called exosomes in as little as 10 minutes. Reporting on their work in the journal, Biosensors and Bioelectronics, the researchers call the work a “significant step” in developing rapid testing and early cancer detection.
Researchers have long sought ways to detect cancer earlier to save more lives. While lab tests to detect tumor biomarkers in blood have been developed, they often can’t find early-stage cancer because the cancer markers are at levels too low to detect. Instead, people most often find out they have cancer through invasive biopsies once tumors are established.In recent years, researchers have discovered that one of the ways cancer cells spread and communicate with other parts of the body is by way of tiny exosome vesicles in blood or other fluids. Ranging in size from 40 to 120 nanometers, or about 1000 times smaller in width than a strand of hair, the exosomes are thought to shuttle molecules from parent cancer cells through the body, entering and then re-programming friendly cells to become cancerous. Cancer cells also secrete more exosome bubbles than regular cells.
“Exosomes provide a unique opportunity as a cancer marker,” Dong said.
However, finding the cancer-filled exosomes in blood testing is challenging. They look the same as normal cell exosomes and other extracellular bubbles, and they are at very low levels in the blood in early cancer.
The WSU team for the first time applied a technology that uses an electric field to rapidly isolate, enrich and detect the exosomes taken from a prostate cancer cell line. The technology was able to concentrate and then separate the cancer-cell exosomes from those from normal cells by way of immune-binding. That is, the researchers captured the target exosomes by using an antibody that is specific to a protein marker on the exosome surface. The researchers were also able to separate out and analyze cancer protein markers within the exosomes. The technology was 33 times more sensitive than conventional methods that are used in research labs to detect and analyze exosomes.
“This has the potential to become a technique capable of concentrating samples by orders of magnitude in minutes,” Dong said.
The researchers demonstrated their technology successfully with a test serum. They are now working to improve it using a greater amount of human blood which, with a confusing mix of hormones, lipids, and other elements floating around, can create a challenging environment for successful testing. The researchers are also working to adjust the power requirements of the technology, so that it can be used portably and more easily in a medical setting.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Cancer blood test
- Docs thought my boy had sickness bug but ‘virus’ turned out to be deadly blood canceron August 9, 2020 at 4:25 am
A SCHOOLBOY was sent home by doctors with a sickness bug – only to be diagnosed with a deadly blood cancer. Lewis Wright, 12, was discharged from hospital with a suspected 72-hour virus and ...
- A Call to Test Men With Prostate Cancer for COVID-19on August 7, 2020 at 8:14 am
A team of New York City urologists proposes that men with prostate cancer get tested for COVID-19 because of their vulnerabilities to the infection.
- Cancer blood test developer Guardant Health signs Silicon Valley's largest office lease of 2020on August 7, 2020 at 4:39 am
Liquid biopsy company Guardant Health Inc. — fresh from raising a multi-million-dollar stock offering — has agreed to lease nearly 250,000 square feet at the former Hewlett Packard Enterprise Co. (HPE ...
- What Young Guys Should Do Now to Prevent Prostate Cancer Lateron August 6, 2020 at 11:45 am
While prostate cancer strikes one in nine men at some point in their lifetimes, guys don't usually think about it until later in life. Now's a good time to not be "usual." Taking these steps now can ...
- Cleveland Clinic studying blood test that detects more than 50 cancerson August 6, 2020 at 11:35 am
The Cleveland Clinic is taking part in a new study focused on a test with the ability to detect more than 50 cancers with a single blood draw. Officials say the PATHFINDER study plans to enroll ...
Go deeper with Google Headlines on:
Cancer blood test
Go deeper with Bing News on:
- FDA OKs Liquid Biopsy to Identify EGFR-Positive Lung Canceron August 7, 2020 at 2:29 pm
The FDA on Friday approved the Guardant360 CDx assay to identify metastatic lung cancer patients who carry specific EGFR mutations, making them eligible for upfront treatment with osimertinib ...
- Assessment of the Global Biomarkers Industry, Forecast to 2026 and the Impact of COVID-19on August 7, 2020 at 1:56 pm
The "Global Biomarkers Market, By Product, Type, Disease Indication, Application, By Region; Trend Analysis, Competitive Market Share & Forecast, 2016-2026" report has been added to ResearchAndMarkets ...
- Digital Biomarkers and Biomarkers Market 2020 Global Analysis, Opportunities And Forecast to 2025on August 6, 2020 at 6:16 pm
The Global digital biomarkers and biomarkers market will show a tremendous CAGR in the forecast period from 2020-2027. Due to the advancing technology like cloud, IoT, and the ado ...
- An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer riskon August 6, 2020 at 2:18 am
Genome wide association studies have identified multiple loci associated with risk of developing prostate cancer but the functional significance of many of these are unknown. Here, after generating ...
- Road Map To Reducing Colorectal Cancer Deathson August 5, 2020 at 11:34 am
Road Map To Reducing Colorectal Cancer DeathsPR NewswireCHICAGO, Aug. 5, 2020Newer, cheaper and more personalized tests means more people tested and more lives savedCHICAGO, Aug.